US 6462042
Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors
expired A61PA61P11/00A61P11/06
Quick answer
US patent 6462042 (Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors) held by Darwin Discovery Limited expires Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Darwin Discovery Limited
- Grant date
- Tue Oct 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P19/00, A61P25/00